Literature DB >> 8629285

Cytomegalovirus prophylaxis in solid organ transplant recipients.

R Patel1, D R Snydman, R H Rubin, M Ho, M Pescovitz, M Martin, C V Paya.   

Abstract

Mesh:

Substances:

Year:  1996        PMID: 8629285     DOI: 10.1097/00007890-199605150-00001

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  24 in total

1.  Role of the laboratory in diagnosis and management of cytomegalovirus infection in hematopoietic stem cell and solid-organ transplant recipients.

Authors:  Raymund R Razonable; Carlos V Paya; Thomas F Smith
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

Review 2.  Passive immunity in prevention and treatment of infectious diseases.

Authors:  M A Keller; E R Stiehm
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

3.  The role of the cytomegalovirus antigenemia assay in the detection and prevention of cytomegalovirus syndrome and disease in solid organ transplant recipients: A review of the British Columbia experience.

Authors:  Erica D Greanya; Nilufar Partovi; Eric M Yoshida; R Jean Shapiro; Robert D Levy; Chris H Sherlock; Gwen M Stephens
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-11       Impact factor: 2.471

Review 4.  Valganciclovir: a review of its use in the management of CMV infection and disease in immunocompromised patients.

Authors:  Risto S Cvetković; Keri Wellington
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients.

Authors:  M D Pescovitz; J Rabkin; R M Merion; C V Paya; J Pirsch; R B Freeman; J O'Grady; C Robinson; Z To; K Wren; L Banken; W Buhles; F Brown
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

Review 6.  Lung transplantation. Part II. Postoperative management and results.

Authors:  D E Wood; G Raghu
Journal:  West J Med       Date:  1997-01

Review 7.  Management of cytomegalovirus infection after solid-organ or stem-cell transplantation. Current guidelines and future prospects.

Authors:  H Hebart; L Kanz; G Jahn; H Einsele
Journal:  Drugs       Date:  1998-01       Impact factor: 9.546

Review 8.  New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients.

Authors:  I G Sia; R Patel
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

9.  Infections after living donor liver transplantation in children.

Authors:  Jeong Eun Kim; Seak Hee Oh; Kyung Mo Kim; Bo Hwa Choi; Dae Yeon Kim; Hyung Rae Cho; Yeoun Joo Lee; Kang Won Rhee; Seong Jong Park; Young Joo Lee; Sung Gyu Lee
Journal:  J Korean Med Sci       Date:  2010-03-19       Impact factor: 2.153

10.  Diagnostic value of monitoring human cytomegalovirus late pp67 mRNA expression in renal-allograft recipients by nucleic acid sequence-based amplification.

Authors:  M J Blok; V J Goossens; S J Vanherle; B Top; N Tacken; J M Middeldorp; M H Christiaans; J P van Hooff; C A Bruggeman
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.